Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)
- 1 September 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (9), 803-806
- https://doi.org/10.1016/0277-5379(82)90188-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- COMBINATION CHEMOTHERAPY SALVAGE OF HEAVILY PRETREATED PATIENTS WITHHODGKINS DISEASE - AN ANALYSIS OF PROGNOSTIC FACTORS IN 2 CHEMOTHERAPY TRIALS AND THE LITERATURE1981
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)Cancer Chemotherapy and Pharmacology, 1979
- Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapyCancer, 1978
- Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)Cancer, 1977
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- PATHOLOGY AND NOMENCLATURE OF HODGKINS DISEASE1966
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965